# BioLineRx Ltd.: Form 6-K, filed Mar 3, 2022

- Company: [BioLineRx Ltd.](/companies/blrx.md) (CIK 1498403)
- Form: 6-K
- Filed: 2022-03-03
- Accepted by EDGAR: Mar 3, 2022, 12:10 ET
- Period: 2022-03-03
- Accession: 0001178913-22-000899
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498403/000117891322000899/zk2227405.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498403/000117891322000899/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498403/000117891322000899/zk2227405.htm

Filed Mar 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001178913-22-000899. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
